RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE SCOPUS

      Cumulative Radiation Exposure during Follow-Up after Curative Surgery for Gastric Cancer

      한글로보기

      https://www.riss.kr/link?id=A104533856

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Objective: To quantify the cumulative effective dose (cED) of radiation due to repeated CT and PET/CT examinations after curative resection of gastric cancer and to assess the lifetime attributable risk (LAR) estimates based on Biological Effects of Ionizing Radiation VII models.
      Subjects and Methods: Patients who underwent a curative resection for gastric cancer between January 2006 and December 2006 and were followed-up until May 2010 were included in this study. The cED was calculated by using the dose-length product values and conversion factors for quantitative risk assessment of radiation exposure. cED and LAR were compared between early and advanced gastric cancer patients and among American Joint Committee on Cancer TNM stage groups (stage I, II, and III). The nonparametric Mann-Whitney U and Kruskal-Wallis tests, followed by a post-hoc analysis with Bonferroni adjustment, were employed as part of the statistical analysis.
      Results: The overall median cED was 57.8 mSv (interquartile range [IQR], 43.9-74.7). The cED was significantly higher in the advanced (median, 67.0; IQR, 49.1-102.3) than in the early gastric cancer group (median, 52.3; IQR, 41.5-67.9) (p < 0.001), and increased as the TNM stage increased. For radiation exposure, 62% of all patients received an estimated cED of over 50 mSv, while 11% of patients received over 100 mSv. The median LAR of cancer incidence was 0.28% (IQR, 0.20-0.40) and there were significant differences between the early gastric cancer and advanced gastric cancer group (p < 0.001) as well as among the three TNM stage groups (p = 0.015). The LAR of cancer incidence exceeded 1% in 2.4% of the patients.
      Conclusion: The cED increases proportionally along with tumor stage and, even in early gastric cancer or stage I patients, cED is much higher than that found among the general population. Considering the very good prognosis of early gastric cancer after curative surgery, the cED should be considered when designing a postoperative follow-up CT protocol.
      번역하기

      Objective: To quantify the cumulative effective dose (cED) of radiation due to repeated CT and PET/CT examinations after curative resection of gastric cancer and to assess the lifetime attributable risk (LAR) estimates based on Biological Effects of I...

      Objective: To quantify the cumulative effective dose (cED) of radiation due to repeated CT and PET/CT examinations after curative resection of gastric cancer and to assess the lifetime attributable risk (LAR) estimates based on Biological Effects of Ionizing Radiation VII models.
      Subjects and Methods: Patients who underwent a curative resection for gastric cancer between January 2006 and December 2006 and were followed-up until May 2010 were included in this study. The cED was calculated by using the dose-length product values and conversion factors for quantitative risk assessment of radiation exposure. cED and LAR were compared between early and advanced gastric cancer patients and among American Joint Committee on Cancer TNM stage groups (stage I, II, and III). The nonparametric Mann-Whitney U and Kruskal-Wallis tests, followed by a post-hoc analysis with Bonferroni adjustment, were employed as part of the statistical analysis.
      Results: The overall median cED was 57.8 mSv (interquartile range [IQR], 43.9-74.7). The cED was significantly higher in the advanced (median, 67.0; IQR, 49.1-102.3) than in the early gastric cancer group (median, 52.3; IQR, 41.5-67.9) (p < 0.001), and increased as the TNM stage increased. For radiation exposure, 62% of all patients received an estimated cED of over 50 mSv, while 11% of patients received over 100 mSv. The median LAR of cancer incidence was 0.28% (IQR, 0.20-0.40) and there were significant differences between the early gastric cancer and advanced gastric cancer group (p < 0.001) as well as among the three TNM stage groups (p = 0.015). The LAR of cancer incidence exceeded 1% in 2.4% of the patients.
      Conclusion: The cED increases proportionally along with tumor stage and, even in early gastric cancer or stage I patients, cED is much higher than that found among the general population. Considering the very good prognosis of early gastric cancer after curative surgery, the cED should be considered when designing a postoperative follow-up CT protocol.

      더보기

      다국어 초록 (Multilingual Abstract)

      Objective: To quantify the cumulative effective dose (cED) of radiation due to repeated CT and PET/CT examinations after curative resection of gastric cancer and to assess the lifetime attributable risk (LAR) estimates based on Biological Effects of Ionizing Radiation VII models.
      Subjects and Methods: Patients who underwent a curative resection for gastric cancer between January 2006 and December 2006 and were followed-up until May 2010 were included in this study. The cED was calculated by using the dose-length product values and conversion factors for quantitative risk assessment of radiation exposure. cED and LAR were compared between early and advanced gastric cancer patients and among American Joint Committee on Cancer TNM stage groups (stage I, II, and III). The nonparametric Mann-Whitney U and Kruskal-Wallis tests, followed by a post-hoc analysis with Bonferroni adjustment, were employed as part of the statistical analysis.
      Results: The overall median cED was 57.8 mSv (interquartile range [IQR], 43.9-74.7). The cED was significantly higher in the advanced (median, 67.0; IQR, 49.1-102.3) than in the early gastric cancer group (median, 52.3; IQR, 41.5-67.9) (p < 0.001), and increased as the TNM stage increased. For radiation exposure, 62% of all patients received an estimated cED of over 50 mSv, while 11% of patients received over 100 mSv. The median LAR of cancer incidence was 0.28% (IQR, 0.20-0.40) and there were significant differences between the early gastric cancer and advanced gastric cancer group (p < 0.001) as well as among the three TNM stage groups (p = 0.015). The LAR of cancer incidence exceeded 1% in 2.4% of the patients.
      Conclusion: The cED increases proportionally along with tumor stage and, even in early gastric cancer or stage I patients, cED is much higher than that found among the general population. Considering the very good prognosis of early gastric cancer after curative surgery, the cED should be considered when designing a postoperative follow-up CT protocol.
      번역하기

      Objective: To quantify the cumulative effective dose (cED) of radiation due to repeated CT and PET/CT examinations after curative resection of gastric cancer and to assess the lifetime attributable risk (LAR) estimates based on Biological Effects of I...

      Objective: To quantify the cumulative effective dose (cED) of radiation due to repeated CT and PET/CT examinations after curative resection of gastric cancer and to assess the lifetime attributable risk (LAR) estimates based on Biological Effects of Ionizing Radiation VII models.
      Subjects and Methods: Patients who underwent a curative resection for gastric cancer between January 2006 and December 2006 and were followed-up until May 2010 were included in this study. The cED was calculated by using the dose-length product values and conversion factors for quantitative risk assessment of radiation exposure. cED and LAR were compared between early and advanced gastric cancer patients and among American Joint Committee on Cancer TNM stage groups (stage I, II, and III). The nonparametric Mann-Whitney U and Kruskal-Wallis tests, followed by a post-hoc analysis with Bonferroni adjustment, were employed as part of the statistical analysis.
      Results: The overall median cED was 57.8 mSv (interquartile range [IQR], 43.9-74.7). The cED was significantly higher in the advanced (median, 67.0; IQR, 49.1-102.3) than in the early gastric cancer group (median, 52.3; IQR, 41.5-67.9) (p < 0.001), and increased as the TNM stage increased. For radiation exposure, 62% of all patients received an estimated cED of over 50 mSv, while 11% of patients received over 100 mSv. The median LAR of cancer incidence was 0.28% (IQR, 0.20-0.40) and there were significant differences between the early gastric cancer and advanced gastric cancer group (p < 0.001) as well as among the three TNM stage groups (p = 0.015). The LAR of cancer incidence exceeded 1% in 2.4% of the patients.
      Conclusion: The cED increases proportionally along with tumor stage and, even in early gastric cancer or stage I patients, cED is much higher than that found among the general population. Considering the very good prognosis of early gastric cancer after curative surgery, the cED should be considered when designing a postoperative follow-up CT protocol.

      더보기

      참고문헌 (Reference)

      1 Murakami T, "gastric cancer" 27 : 115-119, 1971

      2 이혜련, "Treatment results for gastric cancer surgery: 12 years' experience at a single institute in Korea" ELSEVIER SCI LTD 34 : 36-41, 200801

      3 Maehara Y, "Time trends of surgical treatment and the prognosis for japanese patients with gastric cancer" 83 : 986-991, 2000

      4 Icrp publication, "The 2007 recommendations of the international commission on radiological protection" 37 : 1-332, 2007

      5 Sodickson A, "Recurrent ct, cumulative radiation exposure, and associated radiation-induced cancer risks from ct of adults" 251 : 175-184, 2009

      6 안지영, "Recurrence After Curative Resection of Early Gastric Cancer" WILEY-LISS 17 : 448-454, 201002

      7 Kirpalani H, "Radiation risk to children from computed tomography" 121 : 449-450, 2008

      8 Brix G, "Radiation exposure of patients undergoing whole-body dual-modality 18f-fdg pet/ct examinations" 46 : 608-613, 2005

      9 Nunobe S, "Outcome of surgical treatment for patients with locoregional recurrence of gastric cancer" 396 : 161-166, 2011

      10 Deak PD, "Multisection ct protocols: Sex- and age-specific conversion factors used to determine effective dose from dose-length product" 257 : 158-166, 2010

      1 Murakami T, "gastric cancer" 27 : 115-119, 1971

      2 이혜련, "Treatment results for gastric cancer surgery: 12 years' experience at a single institute in Korea" ELSEVIER SCI LTD 34 : 36-41, 200801

      3 Maehara Y, "Time trends of surgical treatment and the prognosis for japanese patients with gastric cancer" 83 : 986-991, 2000

      4 Icrp publication, "The 2007 recommendations of the international commission on radiological protection" 37 : 1-332, 2007

      5 Sodickson A, "Recurrent ct, cumulative radiation exposure, and associated radiation-induced cancer risks from ct of adults" 251 : 175-184, 2009

      6 안지영, "Recurrence After Curative Resection of Early Gastric Cancer" WILEY-LISS 17 : 448-454, 201002

      7 Kirpalani H, "Radiation risk to children from computed tomography" 121 : 449-450, 2008

      8 Brix G, "Radiation exposure of patients undergoing whole-body dual-modality 18f-fdg pet/ct examinations" 46 : 608-613, 2005

      9 Nunobe S, "Outcome of surgical treatment for patients with locoregional recurrence of gastric cancer" 396 : 161-166, 2011

      10 Deak PD, "Multisection ct protocols: Sex- and age-specific conversion factors used to determine effective dose from dose-length product" 257 : 158-166, 2010

      11 Renehan AG, "Impact on survival of intensive follow up after curative resection for colorectal cancer: Systematic review and meta-analysis of randomised trials" 324 : 813-, 2002

      12 Okines A, "Gastric cancer: Esmo clinical practice guidelines for diagnosis, treatment and follow-up" 21 (21): 50-54, 2010

      13 Kodera Y, "Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit" 10 : 898-902, 2003

      14 Hur H, "Follow-up strategy after curative resection of gastric cancer: A nationwide survey in korea" 17 : 54-64, 2010

      15 Whiting J, "Follow-up of gastric cancer: A review" 9 : 74-81, 2006

      16 Fazel R, "Exposure to low-dose ionizing radiation from medical imaging procedures" 361 : 849-857, 2009

      17 Office for Official Publications of the European Communities, "European guidelines on quality criteria for computed tomography Luxembourg"

      18 National Research Council (U.S.)., "Committee to Assess Health Risks from Exposure to Low Level of Ionizing Radiation. Health risks from exposure to low levels of ionizing radiation : Beir vii phase 2" National Academies Press 2006

      19 Park JC, "Clinicopathological aspects and prognostic value with respect to age: An analysis of 3,362 consecutive gastric cancer patients" 99 : 395-401, 2009

      20 Kim JH, "Benefit of post-operative surveillance for recurrence after curative resection for gastric cancer" 14 : 969-976, 2010

      21 Chung HW, "Analysis of demographic characteristics in 3242 young age gastric cancer patients in korea" 16 : 256-263, 2010

      22 Edge SB, "Ajcc cancer staging manual, 7th ed" Springer 2010

      23 Alessio AM, "A pediatric ct dose and risk estimator" 40 : 1816-1821, 2010

      24 대한위암학회 정보전산위원회, "2004년 전국 위암 등록사업 결과 보고" 대한위암학회 7 (7): 47-54, 2007

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2016-11-15 학회명변경 영문명 : The Korean Radiological Society -> The Korean Society of Radiology KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2006-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2003-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.61 0.46 1.15
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.93 0.84 0.494 0.06
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼